Tags: eli | lilly | growth | earnings

Eli Lilly Sees Growth in Earnings Next Year

Thursday, 10 Dec 2009 09:09 AM

Eli Lilly said Thursday it still expects its earnings per share to grow in the double-digit range through 2011 and added it plans to launch two new medicines per year starting in 2013.

The drugmaker expects to earn $4.65 to $4.85 per share in 2010, excluding the impact of health care reform and other items.

On average, analysts expect income of $4.74 per share, according to a survey by Thomson Reuters.

Eli Lilly & Co., which makes the anti-psychotic Zyprexa and the antidepressant Cymbalta, said it has more than 60 molecules in clinical development, including 25 in mid and late-stage development.

In August Lilly debuted blood thinner Effient in the U.S., the company's first new product launch since 2005.

Lilly's fastest-growing product is Alimta, which saw its sales climb 47 percent in the third quarter. Lilly said Thursday it plans to purse additional indications for the cancer drug, either as monotherapy, or in combination with other oncolytics.

Earlier this year, the Indianapolis company said it would cut annual costs by $1 billion by 2011 and produce new drugs faster.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Headline
Eli Lilly said Thursday it still expects its earnings per share to grow in the double-digit range through 2011 and added it plans to launch two new medicines per year starting in 2013.The drugmaker expects to earn $4.65 to $4.85 per share in 2010, excluding the impact of...
eli,lilly,growth,earnings
179
2009-09-10
Thursday, 10 Dec 2009 09:09 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved